Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-010815
Filing Date
2019-11-12
Accepted
2019-11-12 16:24:58
Documents
71
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20190930x10q.htm 10-Q 1958672
2 EX-31.1 hook-20190930ex3118e0e58.htm EX-31.1 12133
3 EX-31.2 hook-20190930ex312aa8835.htm EX-31.2 12148
4 EX-32.1 hook-20190930ex3213a2756.htm EX-32.1 12471
  Complete submission text file 0001558370-19-010815.txt   7291208

Data Files

Seq Description Document Type Size
5 EX-101.INS hook-20190930.xml EX-101.INS 1504105
6 EX-101.SCH hook-20190930.xsd EX-101.SCH 56406
7 EX-101.CAL hook-20190930_cal.xml EX-101.CAL 65906
8 EX-101.DEF hook-20190930_def.xml EX-101.DEF 179413
9 EX-101.LAB hook-20190930_lab.xml EX-101.LAB 490312
10 EX-101.PRE hook-20190930_pre.xml EX-101.PRE 361839
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

EIN.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 191209893
SIC: 2834 Pharmaceutical Preparations